EP0743308A3 - Chinazolinverbindung und diese als Wirkstoff enthaltendes Antitumormittel - Google Patents
Chinazolinverbindung und diese als Wirkstoff enthaltendes Antitumormittel Download PDFInfo
- Publication number
- EP0743308A3 EP0743308A3 EP96106839A EP96106839A EP0743308A3 EP 0743308 A3 EP0743308 A3 EP 0743308A3 EP 96106839 A EP96106839 A EP 96106839A EP 96106839 A EP96106839 A EP 96106839A EP 0743308 A3 EP0743308 A3 EP 0743308A3
- Authority
- EP
- European Patent Office
- Prior art keywords
- compound
- active ingredient
- tumor agent
- agent containing
- quinazoline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
- C07D239/84—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP142559/95 | 1995-05-16 | ||
JP142560/95 | 1995-05-16 | ||
JP14256095 | 1995-05-16 | ||
JP14255995 | 1995-05-16 | ||
JP14256095 | 1995-05-16 | ||
JP14255995 | 1995-05-16 |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0743308A2 EP0743308A2 (de) | 1996-11-20 |
EP0743308A3 true EP0743308A3 (de) | 2000-04-05 |
Family
ID=26474523
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP96106839A Withdrawn EP0743308A3 (de) | 1995-05-16 | 1996-04-30 | Chinazolinverbindung und diese als Wirkstoff enthaltendes Antitumormittel |
Country Status (5)
Country | Link |
---|---|
US (1) | US5912247A (de) |
EP (1) | EP0743308A3 (de) |
KR (1) | KR960041178A (de) |
CN (1) | CN1145361A (de) |
TW (1) | TW334434B (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2194181T3 (es) | 1996-02-13 | 2003-11-16 | Astrazeneca Ab | Derivados de quinazolina como inhibidores de vegf. |
DK0885198T3 (da) | 1996-03-05 | 2002-03-25 | Astrazeneca Ab | 4-Anilinoquinazolinderivater |
GB9707800D0 (en) | 1996-05-06 | 1997-06-04 | Zeneca Ltd | Chemical compounds |
GB9718972D0 (en) | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
US6294532B1 (en) | 1997-08-22 | 2001-09-25 | Zeneca Limited | Oxindolylquinazoline derivatives as angiogenesis inhibitors |
KR100860295B1 (ko) | 1998-10-08 | 2008-09-25 | 아스트라제네카 아베 | 퀴나졸린 유도체 |
ATE339406T1 (de) | 1999-09-23 | 2006-10-15 | Astrazeneca Ab | Chinazoline verbindungen als heilmittel |
KR100881105B1 (ko) | 1999-11-05 | 2009-02-02 | 아스트라제네카 아베 | Vegf 억제제로서의 퀴나졸린 유도체 |
US6140516A (en) * | 1999-12-15 | 2000-10-31 | Eastman Chemical Company | Process for the preparation of trans-3-alkyloxy-4-hydroxytetrahydrofuran |
DE60121931T2 (de) | 2000-04-07 | 2007-03-01 | Astrazeneca Ab | Chinazolinverbindungen |
CN1531441A (zh) * | 2001-01-12 | 2004-09-22 | �о���Ӧ�ÿ�ѧЭ��ɷ�����˾ | 抑制血管增殖的药物组合物及其使用方法 |
EP1852107A1 (de) | 2006-04-19 | 2007-11-07 | Nanobiotix | Zusammensetzungen enthaltend magnetische Nanopartikel sowie deren Verwendung |
EP2508171B1 (de) | 2011-03-25 | 2014-05-07 | Universitätsklinikum Erlangen | Pharmazeutische Zusammensetzung mit magnetischen Nanopartikeln |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0322133A1 (de) * | 1987-12-03 | 1989-06-28 | SmithKline Beecham Intercredit B.V. | Chinazolinon-Derivate |
US4877790A (en) * | 1987-12-15 | 1989-10-31 | Kanebo Limited | Quinazoline derivative, processes for its production, and cerebral dysfunction remedying agent comprising it as active ingredient |
WO1992007844A1 (en) * | 1990-11-06 | 1992-05-14 | Pfizer Inc. | Quinazolines derivatives for enhancing antitumor activity |
EP0635498A1 (de) * | 1993-07-19 | 1995-01-25 | Zeneca Limited | Quinazoline Derivate und ihre Anwendung als Krebsmittel |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1062357A (en) * | 1965-03-23 | 1967-03-22 | Pfizer & Co C | Quinazolone derivatives |
US3812127A (en) * | 1966-10-31 | 1974-05-21 | Pfizer | 4-(quinolin-4-yl)piperazine-1-carboxylic acid esters |
CH651027A5 (de) * | 1982-11-12 | 1985-08-30 | Sandoz Ag | Heterocyclische verbindungen, ihre herstellung und verwendung. |
US4672116A (en) * | 1985-12-20 | 1987-06-09 | Ortho Pharmaceutical Corporation | Substituted 5,6-dialkoxyquinazoline derivatives |
JPH07138238A (ja) * | 1993-11-16 | 1995-05-30 | Kanebo Ltd | 新規キナゾリン誘導体およびそれを有効成分とする抗腫瘍剤 |
-
1996
- 1996-04-20 TW TW085104730A patent/TW334434B/zh active
- 1996-04-30 EP EP96106839A patent/EP0743308A3/de not_active Withdrawn
- 1996-04-30 CN CN96108492A patent/CN1145361A/zh active Pending
- 1996-04-30 KR KR1019960014017A patent/KR960041178A/ko not_active Application Discontinuation
-
1997
- 1997-08-20 US US08/916,946 patent/US5912247A/en not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0322133A1 (de) * | 1987-12-03 | 1989-06-28 | SmithKline Beecham Intercredit B.V. | Chinazolinon-Derivate |
US4877790A (en) * | 1987-12-15 | 1989-10-31 | Kanebo Limited | Quinazoline derivative, processes for its production, and cerebral dysfunction remedying agent comprising it as active ingredient |
WO1992007844A1 (en) * | 1990-11-06 | 1992-05-14 | Pfizer Inc. | Quinazolines derivatives for enhancing antitumor activity |
EP0635498A1 (de) * | 1993-07-19 | 1995-01-25 | Zeneca Limited | Quinazoline Derivate und ihre Anwendung als Krebsmittel |
Non-Patent Citations (2)
Title |
---|
MANABU HORI ET AL.: "Nootropic agents, 4-Alkoxy-2-(1-piperazinyl)quinazoline Derivatives", CHEM. PHARM. BULL., vol. 39, no. 2, 1991, japan, pages 367 - 371, XP002128281 * |
MANABU HORI ET AL.: "Novel 4-Substituted 2-Piperazinylquinazolines as potent Anticonvulsive and Antihypoxic Agents.", CHEM. PHARM. BULL., vol. 38, no. 5, 1990, japan, pages 1286 - 1291, XP002128282 * |
Also Published As
Publication number | Publication date |
---|---|
TW334434B (en) | 1998-06-21 |
US5912247A (en) | 1999-06-15 |
EP0743308A2 (de) | 1996-11-20 |
CN1145361A (zh) | 1997-03-19 |
KR960041178A (ko) | 1996-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2090967A1 (en) | Water soluble camptothecin analogues, processes and methods | |
CA2016659A1 (en) | Stabilized compositions containing epidermal growth factor | |
EP2044938A3 (de) | Radioprotektoren | |
EA199600104A1 (ru) | Повышенная биодоступность биологически активных соединений при связывании с производными полипирролкарбоксамидонафталиновой кислоты | |
CA2278201A1 (en) | Novel modifications to 2-amino-4-(4-fluorobenzylamino)-1-ethoxycarbonyl-aminobenzene, and processes for their preparation | |
CA2232310A1 (en) | Stable compositions containing n-propargyl-1-aminoindan | |
EP0743308A3 (de) | Chinazolinverbindung und diese als Wirkstoff enthaltendes Antitumormittel | |
MY110526A (en) | Thioether conjugates | |
CA2216623A1 (en) | Use of fumagillol and derivatives thereof for preparing medicaments against intestinal infections | |
WO2001047479A3 (en) | Skin moisturizing composition | |
PL311122A1 (en) | Water-solublederivatives of camptotectin, method of obtaining them and their application as anticarcinogenic agents | |
CA2015475A1 (en) | Treating agent for osteoarthritis | |
EP0165458A3 (de) | (+/-)-Ambrox, Verfahren zu seiner Herstellung und seiner Verwendung | |
CA2013166A1 (en) | Suppression of parathyroid hormone synthesis and secretion | |
CA2129542A1 (en) | Pharmaceutical preparation based on rhamnolipid | |
EP0198686A3 (de) | Dioxolanmethansulfamate als Antikonvulsiva | |
EP1207152A3 (de) | Pestizide | |
EP0327709A3 (de) | Platin-Komplex, diesen enthaltendes antineoplastisches Agens, Zwischenprodukt, Verfahren zur Herstellung und Verwendung | |
EP1219288A3 (de) | Zusammensetzung zur Hautbehandlung | |
EP0138344A3 (de) | Pyridazinonen als beta-adrenergetische Antagonisten | |
EP0328203A3 (de) | [5(6)-(1H-Azol-1-ylmethyl)Benzimidazol]-Karbamate | |
EP0031584A3 (de) | 2-Substituierte Aminopropen- und Propannitril-Verbindungen und anti-mikrobielle und anti-inflammatorische pharmazeutische Zusammensetzungen | |
EP0371388A3 (de) | Acridin-Derivate | |
EP1074554A3 (de) | 7-Acyl-3-(substituierte Carbamoyloxy) Cephemverbindungen, deren Verwendung und Verfahren zu ihrer Herstellung | |
WO2000035945A8 (en) | Cyclic peptide antifungal agents having a sugar substituent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE |
|
PUAL | Search report despatched |
Free format text: ORIGINAL CODE: 0009013 |
|
AK | Designated contracting states |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: AKZO NOBEL N.V. |
|
17P | Request for examination filed |
Effective date: 20000908 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
18W | Application withdrawn |
Withdrawal date: 20010123 |